Correction to: Nature https://doi.org/10.1038/s41586-024-07121-9 Published online 28 February 2024
In the version of the article initially published, the Data availability section did not include the accession codes for the sequencing data generated in this study (available from the Gene Expression Omnibus (GEO) repository under accession code GSE260816) and the clinical study data (available from the European Genome-Phenome Archive (EGA) under the accession code EGAS50000000251). The HTML and PDF versions of the article have now been updated.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Guan, X., Hu, R., Choi, Y. et al. Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. Nature 633, E1 (2024). https://doi.org/10.1038/s41586-024-07956-2
Published:
Issue date:
DOI: https://doi.org/10.1038/s41586-024-07956-2
